• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,927.61 57.71
(0.11%)
Dow Jones
7,374.18 -5.04
(-0.07%)
Hang Seng
72,467.78 3,292.81
(4.76%)
Nikkei 225
10,536.79 75.16
(0.72%)
Forex
USD-INR
94.74 0.21
(0.22%)
EUR-INR
108.00 -0.19
(-0.17%)
GBP-INR
125.20 0.11
(0.09%)
JPY-INR
0.59 0.00
(0.26%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
148.85
446792.16
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.86
 

Avro India standalone net profit rises 65.38% in the March 2026 quarter
Jun 01,2026
Net profit of Avro India rose 65.38% to Rs 0.86 crore in the quarter ended March 2026 as against Rs 0.52 crore during the previous quarter ended March 2025. Sales rose 23.29% to Rs 24.03 crore in the quarter ended March 2026 as against Rs 19.49 crore during the previous quarter ended March 2025.

For the full year,net profit rose 38.49% to Rs 4.21 crore in the year ended March 2026 as against Rs 3.04 crore during the previous year ended March 2025. Sales rose 16.18% to Rs 90.99 crore in the year ended March 2026 as against Rs 78.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales24.0319.49 23 90.9978.32 16
OPM %1.043.90 -3.516.52 -
PBDT2.342.05 14 9.898.11 22
PBT1.160.85 36 5.464.19 30
NP0.860.52 65 4.213.04 38